| SUPN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SUPN market cap history going back to 5/1/2012:
Also see: SUPN Shares Outstanding History and SUPN YTD Return |
SUPN Market Cap History — Supernus Pharmaceuticals Capitalization Over Time
As of 4/28/2026 Supernus Pharmaceuticals has a market cap of 2.83 billion. Investors often follow the SUPN market cap history to compare the size of the company over time.
This page shows SUPN market capitalization trends over time, with 57 market cap datapoints presented, dating back to 5/1/2012.
| SUPN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SUPN Historical Market Cap: +24.34% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUPN Stock Price Chart |
| About Supernus Pharmaceuticals Inc |
| Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. Co. is also developing a range of novel CNS product candidates, including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. We show 57 historical shares outstanding datapoints in our SUPN shares outstanding history coverage, used to compute SUPN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SUPN market cap history over the course of time is important for investors interested in comparing SUPN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SUPN versus a peer is one thing; comparing SUPN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SUPN can fluctuate over the course of history. With this page we aim to empower investors researching SUPN by allowing them to research the SUPN market cap history. |
| SUPN Current Stock Quote |
Quotes delayed 20 minutes  Free SUPN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SUPN Share Performance |
| Market Cap Peers |
| Supernus Pharmaceuticals (SUPN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SURF Market Cap History SVA Market Cap History SVRA Market Cap History SWAV Market Cap History SWTX Market Cap History SXTP Market Cap History SYBX Market Cap History SYK Market Cap History SYNH Market Cap History SYRA Market Cap History More Healthcare companies » |
SUPN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
